Evidence map›Paper›PMID 37199147›Full record

ArticleCirculation2023

Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.

Shumei Man, Nicole Solomon, Brian Mac Grory, Brooke Alhanti, Ken Uchino, Jeffrey L Saver, Eric E Smith, Ying Xian, Deepak L Bhatt, Lee H Schwamm and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Shumei ManDepartment of Neurology, Cerebrovascular Center, Neurological Institute, Cleveland Clinic, OH (S.M., K.U., M.S.H.).ORCID 0000-0002-8345-6470
Nicole SolomonDuke Clinical Research Institute, Duke University, Durham, NC (N.S., B.A.).ORCID 0000-0002-5643-9958
Brian Mac GroryDepartment of Neurology, Duke University School of Medicine, Durham, NC (B.M.G.).ORCID 0000-0003-3914-8419
Brooke AlhantiDuke Clinical Research Institute, Duke University, Durham, NC (N.S., B.A.).ORCID 0000-0003-4243-8062
Ken UchinoDepartment of Neurology, Cerebrovascular Center, Neurological Institute, Cleveland Clinic, OH (S.M., K.U., M.S.H.).ORCID 0000-0001-9468-4172
Jeffrey L SaverDepartment of Neurology, University of California, Los Angeles (J.L.S.).ORCID 0000-0001-9141-2251
Eric E SmithDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada (E.E.S.).ORCID 0000-0003-3956-1668
Ying XianDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas (Y.X.).ORCID 0000-0002-1237-1162
Deepak L BhattMount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY (D.L.B.).ORCID 0000-0002-1278-6245
Lee H SchwammDepartment of Neurology, Massachusetts General Hospital, Boston (L.H.S.).ORCID 0000-0003-0592-9145
Muhammad Shazam HussainDepartment of Neurology, Cerebrovascular Center, Neurological Institute, Cleveland Clinic, OH (S.M., K.U., M.S.H.).
Gregg C FonarowDivision of Cardiology, University of California, Los Angeles (G.C.F.).ORCID 0000-0002-3192-8093
The Neurological Institute · USClinical Research Institute · USUniversity of California, Los Angeles · USAllen Institute for Brain Science · USDuke University · USMassachusetts General Hospital · USMount Sinai Health System · USSouthwestern Medical Center · US

Funding

New England Regional Coordinating Center for the NINDS Stroke Trials Network (StrokeNet)U24NS107243 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANEESH B SINGHAL · 2018 to 2026
$3.3M
The Impact of Telestroke on Patterns of Care and Long-Term OutcomesR01NS111952 · NINDS · HARVARD MEDICAL SCHOOL · PI MEHROTRA, ATEEV · 2019 to 2023
$2.4M
Cardioembolism as a Mechanism of Central Retinal Artery OcclusionK23HL161426 · NHLBI · DUKE UNIVERSITY · PI Brian Mac Grory · 2022 to 2026
$951k
American Heart Association-American Stroke Association 15CRP23100013NHLBI NIH HHS K23 HL161426NINDS NIH HHS R01 NS111952NINDS NIH HHS U24 NS107243
6 · The paper itself

Abstract

backgroundExisting data and clinical trials could not determine whether faster intravenous thrombolytic therapy (IVT) translates into better long-term functional outcomes after acute ischemic stroke among those treated with endovascular thrombectomy (EVT). Patient-level national data can provide the required large population to study the associations between earlier IVT, versus later, with longitudinal functional outcomes and mortality in patients receiving IVT+EVT combined treatment.

methodsThis cohort study included older US patients (age ≥65 years) who received IVT within 4.5 hours or EVT within 7 hours after acute ischemic stroke using the linked 2015 to 2018 Get With The Guidelines-Stroke and Medicare database (38 913 treated with IVT only and 3946 with IVT+EVT). Primary outcome was home time, a patient-prioritized functional outcome. Secondary outcomes included all-cause mortality in 1 year. Multivariate logistic regression and Cox proportional hazards models were used to evaluate the associations between door-to-needle (DTN) times and outcomes.

resultsAmong patients treated with IVT+EVT, after adjusting for patient and hospital factors, including onset-to-EVT times, each 15-minute increase in DTN times for IVT was associated with significantly higher odds of zero home time in a year (never discharged to home) (adjusted odds ratio, 1.12 [95% CI, 1.06-1.19]), less home time among those discharged to home (adjusted odds ratio, 0.93 per 1% of 365 days [95% CI, 0.89-0.98]), and higher all-cause mortality (adjusted hazard ratio, 1.07 [95% CI, 1.02-1.11]). These associations were also statistically significant among patients treated with IVT but at a modest degree (adjusted odds ratio, 1.04 for zero home time, 0.96 per 1% home time for those discharged to home, and adjusted hazard ratio 1.03 for mortality). In the secondary analysis where the IVT+EVT group was compared with 3704 patients treated with EVT only, shorter DTN times (≤60, 45, and 30 minutes) achieved incrementally more home time in a year, and more modified Rankin Scale 0 to 2 at discharge (22.3%, 23.4%, and 25.0%, respectively) versus EVT only (16.4%,

conclusionsAmong older patients with stroke treated with either IVT only or IVT+EVT, shorter DTN times are associated with better long-term functional outcomes and lower mortality. These findings support further efforts to accelerate thrombolytic administration in all eligible patients, including EVT candidates.

Indexed as

Brain IschemiaEndovascular ProceduresIschemic StrokeStrokeAgedCohort StudiesFibrinolytic AgentsHumansMedicareThrombectomyThrombolytic TherapyTreatment OutcomeUnited StatesFibrinolytic Agentsischemic strokepatient outcome assessmentthrombectomythrombolytic therapy

Identifiers

PMID37199147
PMCPMC10356148
OpenAlexW4377010787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.